trandolapril: Clinical Trials

12 trials of trandolapril, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

8 completed, 1 enrolling by invitation, 1 recruiting, 1 suspended. 12 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 412Completed 8, Enrolling by invitation 1, Recruiting 1, Suspended 1, Unknown 1

Follow trandolapril: new trials by email Literature Review of trandolapril trials Research Report on trandolapril

Trials (filtered) newest first · largest first

All 12 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Rapid and Simultaneous Initiation of Four Guideline-Directed CKD Therapies (RAPID-CKD)
Finerenone, Semaglutide, Lotensin - Chronic Kidney Disease, Type 2 Diabetes
Phase 4Enrolling by invitationBaylor Research Institute642026-04-082026-10-13
Coronavirus (COVID-19) ACEi/ARB Investigation
Thiazide or Thiazide-like diuretics, Calcium Channel Blockers, ACE inhibitor - Hypertension, COVID-19
Phase 4SuspendedNational University of Ireland, Galway, Ireland24142020-04-302020-06-30
NT-proBNP Selected Prevention of Cardiac Events in Diabetic Patients
RAS-antagonist and beta-blocker up-to maximal dosages, RAS-antagonist and beta-blocker none or at stable dose - Heart Diseases, Diabetes Mellitus, Type 2
Phase 4RecruitingMartin Huelsmann24002016-02-012023-03-14
Chronic Angiotensin Converting Enzyme Inhibitors in Intermediate Risk Surgery
ACEI continuation, ACEI omission - Hypotension on Induction
Phase 4CompletedUniversity of Nebraska2912015-06-012023-09-25
Metabolic Effects of Antihypertensive Drugs on People With Metabolic Syndrome (The MEAD Study)
Hydrochlorothiazide, Trandolapril - Hypertension
Phase 4CompletedUniversity of Florida242007-05-012014-06-17
Evaluation of Heart Failure Treatment Guided by N-terminal Pro B-type Natriuretic Peptide (NTproBNP) vs Clinical Symptoms and Signs Alone
Captopril, Enalapril, Lisinopril - Heart Failure, Ventricular Dysfunction, Left
Phase 4CompletedAstraZeneca2522006-10-012012-06-25
Acute Haemodynamic Effects of Treatment With Angiotensin Converting Enzyme (ACE)-Inhibitors in Patients With Symptomatic Aortic Stenosis
Captopril and Trandolapril, Captopril Test Dose and Trandolapril - Aortic Stenosis
Phase 4UnknownCopenhagen University Hospital, Rigshospitalet642005-11-012008-09-03
Russian Study of the Efficacy and Safety of Tarka in Patients With Hypertension
trandolapril/verapamil - Hypertension
Phase 4CompletedAbbott1202004-06-012008-07-10
Tarka vs. Hyzaar in Patients With Metabolic Syndrome (STAR)
trandolapril/verapamil, (Hyzaar) losartan/hydrochlorothiazide - Hypertension, Metabolic Syndrome
Phase 4CompletedAbbott2802004-03-012008-07-15
Canadian Study of Trandolapril on Blood Pressure in Hypertensive Patients (TRAIL)
Trandolapril - Hypertension
Phase 4CompletedAbbott20002004-03-012008-07-22
Tarka® vs. Lotrel® in Hypertensive, Diabetic Subjects With Renal Disease (TANDEM)
trandolapril/verapamil, Lotrel (amlodipine/benazepril) - Hypertension, Diabetes
Phase 4CompletedAbbott3572004-01-012008-07-15
A Study for Prevention of Kidney Disease in Diabetic Patients (BENEDICT)
trandolapril, trandolapril/verapamil, placebo - Hypertension, Diabetes
Phase 4CompletedAbbott12041997-03-012008-07-15

Conditions studied

Hypertension (7)  ·  Albuminuria (2)  ·  Diabetes Mellitus (2)  ·  Diabetes Mellitus, Type 2 (2)  ·  Metabolic Syndrome (2)  ·  Aortic Valve Stenosis (1)  ·  COVID-19 (1)  ·  Cardiovascular Diseases (1)  ·  Coronavirus Infections (1)  ·  Glucose Intolerance (1)  ·  Heart Diseases (1)  ·  Heart Failure (1)  ·  Hyperkalemia (1)  ·  Obesity, Abdominal (1)  ·  Proteinuria (1)

Sponsors

Abbott (5)  ·  AstraZeneca (1)  ·  Baylor Research Institute (1)  ·  Copenhagen University Hospital, Rigshospitalet (1)  ·  Martin Huelsmann (1)  ·  National University of Ireland, Galway, Ireland (1)  ·  University of Florida (1)  ·  University of Nebraska (1)

Countries

United States (4)  ·  Austria (1)  ·  Denmark (1)  ·  Ireland (1)  ·  Netherlands (1)  ·  New Zealand (1)  ·  Spain (1)  ·  Sweden (1)  ·  United Kingdom (1)

Top investigators

Bjorn Eriksson, MD (1)  ·  Christian Hassager, MD, Phd (1)  ·  Hans Persson, MD, PhD (1)  ·  Jason F Shiffermiller, MD, MPH (1)  ·  John William McEvoy, MBBCh MHS (1)  ·  Martin Huelsmann, Doz.Dr. (1)  ·  Morten Dalsgaard, MD (1)  ·  Peer Grande, MD, Phd (1)  ·  Peter Clemmensen, MD, Phd (1)  ·  Rhonda M. Cooper-DeHoff, Pharm D, MS (1)  ·  Victor Gorin, MD (1)

Results publications

PMID 17130190, PMID 18443191, PMID 20139439, PMID 21243736, PMID 22773704, PMID 23733198, PMID 30261084

NIH funding

K23HL086558 (1)